Most Active
APLD 18,342
FUBO 37,735
BLRX 7,478
TLRY 35,221
PTON 16,430
LCID 85,881
ADTX 14,924
BMRA 7,925
SOUN 72,922
DNN 23,208
ACON 20,296
RVPH 2,779
KOS 9,497
TNXP 114,935
SPRC 8,575
HIMS 16,422
ITRM 3,118
| Ticker: | IRD |
| Current Price: | $1.14 |
| % Daily Change: | -0.87% |
| Volume: | 77 |
| Average Volume: | 225 |
| Market Cap: | $36 |
| 1/2/2024 Price: | $3.07 |
| Change Since Inception: | -62.9% |
Opus Genetics, Inc.
37000 Grand River Avenue
Suite 120
Farmington Hills, MI 48335
United States
Ocuphire Pharma, Inc. and Opus Genetics have combined under the Opus Genetics name (Nasdaq: IRD). As a combined company, we are committed to building an innovative, efficient and sustainable clinical-stage ophthalmic biopharmaceutical company leading the development of transformative gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders.